Primary liver cancer remains a global health challenge due to rising incidence, limited curative options, and poor overall survival. Poor outcomes stem from tumor heterogeneity, limited efficacy of current therapies, and co-morbid chronic liver disease. Despit... ...

请注册登录后继续浏览